Mpox Outbreak in Africa: Singapore and Africa CDC Collaborate

By Crystal Lubbe

November 20, 2024

The article from the Africa CDC website titled “Singapore’s Health Ministry and Africa CDC Announce Joint Efforts to Tackle the Mpox Outbreak” emphasises the collaborative efforts being made to manage the mpox outbreak in Africa. The focus on mpox is highlighted through various initiatives and actions aimed at controlling the spread of this disease.

Declaration of Public Health Emergencies

On August 13, 2024, Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS), followed by the World Health Organization (WHO) declaring it a Public Health Emergency of International Concern (PHEIC) on August 14, 2024, in response to its global spread.

Impact and Spread

As of November 2024, the outbreak has affected 19 African Union member states, with over 12,000 confirmed cases reported since the start of the year. Cases in the Democratic Republic of the Congo (DRC) and Burundi primarily drive the outbreak.

Collaborative Efforts

The Ministry of Health, Singapore, is providing a support package to Africa CDC, which includes essential mpox diagnostic kits and testing supplies. This support enables the performance of up to 50,000 tests, strengthening Africa CDC’s capacity for enhanced mpox case management.

Diagnostic and Testing Challenges

One major challenge in controlling the mpox outbreak in Africa has been the shortage of vital testing supplies. In response, Africa CDC and WHO have initiated a joint plan to expand mpox testing, including scaling up PCR testing capacity and deploying near point-of-care testing. Therefore, they are also training laboratory personnel and supplying adequate testing materials.

Comprehensive Continental Response Plan

For the first time, Africa CDC has developed a comprehensive continental response plan for disease outbreaks, focusing on all pillars of outbreak response, including enhanced diagnostics and genome sequencing. This plan coordinates efforts across essential areas such as risk communication and infection prevention.

Vaccine Allocation and Deployment

The Access and Allocation Mechanism (AAM) has allocated vaccine doses to countries most affected by the outbreak. Furthermore, following a phased vaccination strategy aimed at high-risk populations.

International Cooperation

The joint-efforts-to-combat-mpox-outbreak-response emphasises a commitment to international cooperation in public health. This cooperation is vital for effectively managing the mpox outbreak and ensuring global health security.

In conclusion, the mpox outbreak’s severe impact in Africa prompted collaborative efforts by Africa CDC, WHO, and Singapore. These organisations are enhancing diagnostic and testing capabilities and deploying a comprehensive response plan to manage the mpox outbreak effectively. The commitment to fight mpox demonstrates the critical nature of global health cooperation.

Reference url

Recent Posts

lenacapavir HIV prevention
      

Lenacapavir HIV Prevention: Approval and Access Strategy Updates

🌍 *Could a twice-yearly shot revolutionize HIV prevention?*
Gilead Sciences has submitted key applications to the EMA for lenacapavir, a groundbreaking HIV-1 capsid inhibitor designed for use as pre-exposure prophylaxis (PrEP). With promising trial results indicating a significant reduction in HIV infections, this innovation could enhance adherence to prevention strategies globally. Discover more about this game-changing development!

#SyenzaNews #globalhealth #healthcareInnovation

Africa health partnership
      

Strengthening Africa Health Partnership

🌍 Can collaboration redefine Africa’s health landscape?

A newly signed Memorandum of Understanding between Africa CDC and Global Health EDCTP3 promises to enhance health research, clinical trials, and pandemic preparedness on the continent. With a focus on training, local manufacturing, and equitable partnerships, this initiative aims to address pressing global health challenges while improving health outcomes across Africa.

Look into the details of this transformative partnership and its implications for the future of healthcare in the region!

#SyenzaNews #globalhealth #HealthcareInnovation

breast cancer Africa
    

Urgent Call for Enhanced Breast Cancer Africa Control Measures

🚨 Are we doing enough to tackle the imminent breast cancer crisis in Africa?

A recent WHO report reveals alarming trends, predicting that 135,000 women could succumb to breast cancer by 2040 unless urgent actions are taken. The report highlights critical gaps in healthcare infrastructure and capacity, emphasizing the need for investment in screening programs and professional training to improve outcomes across the continent.

Review the full article to explore the necessary steps towards reinforcing breast cancer control measures in Africa.

#SyenzaNews #globalhealth #oncology #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.